Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
Crossref DOI link: https://doi.org/10.1186/s12885-015-1686-y
Published Online: 2015-10-15
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Honma, Naoko
Horii, Rie
Ito, Yoshinori
Saji, Shigehira
Younes, Mamoun
Iwase, Takuji
Akiyama, Futoshi
License valid from 2015-10-15